Blazar BR - Search Results

1

Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.

Vallera DA, Taylor PA, Aukerman SL, Blazar BR. Vallera DA, et al. Among authors: blazar br. Cancer Res. 1993 Sep 15;53(18):4273-80. Cancer Res. 1993. PMID: 8364923

2

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha.

Blazar BR, Widmer MB, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1992 Sep 15;80(6):1614-22. Blood. 1992. PMID: 1369829 Free article.

3

Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.

Vallera DA, Carroll SF, Brief S, Blazar BR. Vallera DA, et al. Among authors: blazar br. Diabetes. 1992 Apr;41(4):457-64. doi: 10.2337/diab.41.4.457. Diabetes. 1992. PMID: 1376702

4

Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.

Blazar BR, Aukerman SL, Vallera DA. Blazar BR, et al. Blood. 1992 Mar 15;79(6):1636-42. Blood. 1992. PMID: 1547353 Free article.

5

Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis.

Orchard PJ, Dahl N, Aukerman SL, Blazar BR, Key LL Jr. Orchard PJ, et al. Among authors: blazar br. Exp Hematol. 1992 Jan;20(1):103-5. Exp Hematol. 1992. PMID: 1577090

6

General strategies in in vivo animal modeling.

Vallera DA, Blazar BR. Vallera DA, et al. Among authors: blazar br. Targeted Diagn Ther. 1992;7:63-77. Targeted Diagn Ther. 1992. PMID: 1633310 Review. No abstract available.

7

T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.

Filipovich AH, Vallera D, McGlave P, Polich D, Gajl-Peczalska K, Haake R, Lasky L, Blazar B, Ramsay NK, Kersey J, et al. Filipovich AH, et al. Transplantation. 1990 Sep;50(3):410-5. doi: 10.1097/00007890-199009000-00011. Transplantation. 1990. PMID: 1698319

8

Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis.

Katsanis E, Bausero MA, Ochoa AC, Loeffler CM, Blazar BR, Leonard AS, Anderson PM. Katsanis E, et al. Among authors: blazar br. Cancer Immunol Immunother. 1991;34(2):74-8. doi: 10.1007/BF01741339. Cancer Immunol Immunother. 1991. PMID: 1760819 Free PMC article.

9

In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.

Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA. Blazar BR, et al. J Immunol. 1991 Sep 1;147(5):1492-503. J Immunol. 1991. PMID: 1831826

10

Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.

Blazar BR, Carroll SF, Vallera DA. Blazar BR, et al. Blood. 1991 Dec 1;78(11):3093-102. Blood. 1991. PMID: 1954395 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

902 results

Search Page

Filters